Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $12.1 million.

  • Medifast's Deferred Taxes rose 26105.35% to $12.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.5 million, marking a year-over-year increase of 25480.21%. This contributed to the annual value of $11.5 million for FY2025, which is 25480.21% up from last year.
  • Latest data reveals that Medifast reported Deferred Taxes of $12.1 million as of Q4 2025, which was up 26105.35% from -$648000.0 recorded in Q3 2025.
  • In the past 5 years, Medifast's Deferred Taxes registered a high of $12.1 million during Q4 2025, and its lowest value of -$7.5 million during Q4 2024.
  • Moreover, its 5-year median value for Deferred Taxes was $0.0 (2025), whereas its average is $44928.6.
  • Per our database at Business Quant, Medifast's Deferred Taxes soared by 71605.84% in 2023 and then plummeted by 71132.08% in 2025.
  • Medifast's Deferred Taxes (Quarter) stood at -$3.7 million in 2021, then skyrocketed by 122.13% to $822000.0 in 2022, then surged by 716.06% to $6.7 million in 2023, then tumbled by 212.08% to -$7.5 million in 2024, then soared by 261.05% to $12.1 million in 2025.
  • Its last three reported values are $12.1 million in Q4 2025, -$648000.0 for Q3 2025, and -$20000.0 during Q2 2025.